Effects of vinblastine on noradrenergic axons.
1 The effects of vinblastine and 6-hydroxydopamine (6-OHDA) on various parameters of adrenergic neurone functions in the rat were examined and compared.2 During the first 12 h after injection of vinblastine, although the concentration of cardiac noradrenaline was unaltered, the turnover rate of the catecholamine in the heart was reduced to 40 ng g(-1) h(-1) compared to a rate of 66 ng g(-1) h(-1) in the hearts of animals treated with 0.9% w/v NaCl solution.3 The uptake of noradrenaline by rat atria in vitro was inhibited by vinblastine (2.5 x 10(-4) M) or 6-OHDA (5 x 10(-5) M), but only the inhibitory effect of vinblastine was readily reversible. The in vitro uptake of noradrenaline by atria of vinblastine- or 6-OHDA-treated rats was found to be impaired two days after injection of the drugs. After 14 days, however, the noradrenaline uptake was 71% of control values after vinblastine and 91% after 6-OHDA.4 In addition to intensely fluorescent nerve trunks in epicardial connective tissue septa, a decrease in the number of fluorescent adrenergic terminals in the atria and ventricles could be observed two days after vinblastine injection. It is suggested that intravenous vinblastine treatment, like 6-OHDA, results in the destruction of adrenergic nerve terminals.
D000818:Animals; D001369:Axons / Q000187:drug effects*; D005453:Fluorescence; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000378:metabolism; D006352:Heart Ventricles / Q000378:metabolism; D006651:Histocytochemistry; D006892:Hydroxydopamines / Q000494:pharmacology; D007498:Iris / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014316:Tritium; D014747:Vinblastine / Q000494:pharmacology*
D006892:Hydroxydopamines; D014316:Tritium; D014747:Vinblastine; D009638:Norepinephrine